{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:23Z","timestamp":1793726003289,"version":"4.6.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["14603"],"award-info":[{"award-number":["14603"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.esmorw.2025.100680","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:01:07Z","timestamp":1769788867000},"page":"100680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study"],"prefix":"10.1016","volume":"11","author":[{"given":"V.","family":"Vavassori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pavarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-5847","authenticated-orcid":false,"given":"L.","family":"Alborghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aimonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5538-3983","authenticated-orcid":false,"given":"A.","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1707-7331","authenticated-orcid":false,"given":"P.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-5684","authenticated-orcid":false,"given":"A.","family":"Bianculli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Ubeira-Gabellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Salmoiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7135-4506","authenticated-orcid":false,"given":"B.","family":"Avuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-2750","authenticated-orcid":false,"given":"T.","family":"Giandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-8986","authenticated-orcid":false,"given":"F.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Noris Chiorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1113-4672","authenticated-orcid":false,"given":"J.M.","family":"Waskiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.G.","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-603X","authenticated-orcid":false,"given":"T.","family":"Rancati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-8494","authenticated-orcid":false,"given":"C.","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cozzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmorw.2025.100680_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/1097-0142(197603)37:3<1417::AID-CNCR2820370324>3.0.CO;2-N","article-title":"The effect of radiation therapy on lymphocyte subpopulations in cancer patients","volume":"37","author":"Raben","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.esmorw.2025.100680_bib2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis","volume":"15","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol. Hematol"},{"key":"10.1016\/j.esmorw.2025.100680_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2217\/fon-2021-0483","article-title":"A systematic review and meta-analysis of the impact of radiation-related lymphopenia on outcomes in pancreatic cancer","volume":"18","author":"Venkatesulu","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/COC.0b013e3182940ff9","article-title":"The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma","volume":"38","author":"Wild","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on Radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-019-0238-9","article-title":"Assessing the interactions between radiotherapy and antitumour immunity","volume":"16","author":"Grassberger","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2016.01.022","article-title":"Hematologic toxicity in patients treated with postprostatectomy whole-pelvis irradiation with different intensity modulated radiation therapy techniques is not negligible and is prolonged: preliminary results of a longitudinal, observational study","volume":"95","author":"Cozzarini","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.esmorw.2025.100680_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2021.02.029","article-title":"Hematological toxicity in patients with solid malignant tumors treated with radiation \u2013 temporal analysis, dose response and impact on survival","volume":"158","author":"Terrones-Campos","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib14","first-page":"840","article-title":"Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer","volume":"39","author":"O\u2019Toole","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.esmorw.2025.100680_bib15","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1002\/mp.15584","article-title":"A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy","volume":"49","author":"Ebrahimi","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib16","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac16ea","article-title":"HEDOS-a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations","volume":"66","author":"Shin","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.esmorw.2025.100680_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ijrobp.2023.01.054","article-title":"Predicting severity of radiation induced lymphopenia in individual proton therapy patients for varying dose rate and fractionation using dynamic 4-dimensional blood flow simulations","volume":"116","author":"McCullum","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00004032-199704000-00001","article-title":"Early dose assessment following severe radiation accidents","volume":"72","author":"Goans","year":"1997","journal-title":"Health Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib19","article-title":"Lymphocyte depletion rate as a biomarker of radiation dose to circulating lymphocytes during fractionated partial-body radiation therapy","volume":"7","author":"Ellsworth","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"11","key":"10.1016\/j.esmorw.2025.100680_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1496881","article-title":"Impact of curative radiotherapy on the immune status of patients with localized prostate cancer","volume":"7","author":"Eckert","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100680_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.esmorw.2025.100680_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-sparing radiotherapy: the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy","volume":"30","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2015.11.013","article-title":"Lymphopenia and its association with survival in patients with locally advanced cervical cancer","volume":"140","author":"Wu","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib28","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international multicentre, randomized phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.esmorw.2025.100680_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2022.08.001","article-title":"Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation","volume":"175","author":"Cozzarini","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib30","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose\u2013volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib32","article-title":"NTCP modeling and dose-volume correlations of significant hematocrit drops 3 months after prostate radiation therapy","volume":"9","author":"Papanikolaou","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/07357907.2021.1960992","article-title":"A systematic review of radiation-related lymphopenia in genito-urinary malignancies","volume":"39","author":"Elumalai","year":"2021","journal-title":"Cancer Invest"},{"key":"10.1016\/j.esmorw.2025.100680_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103497","article-title":"The impact of pelvic nodal radiotherapy on hematologic toxicity: a systematic review with focus on leukopenia, lymphopenia and future perspectives in prostate cancer treatment","volume":"168","author":"Iorio","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.esmorw.2025.100680_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110230","article-title":"Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer","volume":"195","author":"Pavarini","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer","volume":"4","author":"Schad","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fonc.2020.01207","article-title":"Predictors of 2-year incidence of patient-reported urinary incontinence after post-prostatectomy radiotherapy: evidence of dose and fractionation effects","volume":"10","author":"Bresolin","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2021.02.026","article-title":"Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study","volume":"158","author":"Bresolin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0360-3016(94)90138-4","article-title":"Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer","volume":"28","author":"Roach","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmorw.2025.100680_bib40","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.esmorw.2025.100680_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.03.008","article-title":"Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy","volume":"135","author":"Joseph","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/CBM-210292","article-title":"Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer","volume":"34","author":"Yang","year":"2022","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.esmorw.2025.100680_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.937934","article-title":"High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer","volume":"12","author":"Joseph","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib44","series-title":"National Institutes of Health, US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0","year":"2009"},{"key":"10.1016\/j.esmorw.2025.100680_bib45","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.esmorw.2025.100680_bib46","series-title":"Clinical Prediction Models","author":"Steyerberg","year":"2019"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100680_bib47","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0962280214558972","article-title":"Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.esmorw.2025.100680_bib48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/fon.13.237","article-title":"Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume","volume":"10","author":"Pinkawa","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.esmorw.2025.100680_bib49","first-page":"2803","article-title":"Hematologic toxicity of conformal radiotherapy and intensity modulated radiotherapy in prostate and bladder cancer patients","volume":"19","author":"Miszczyk","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.esmorw.2025.100680_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102644","article-title":"Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - a proton versus photon comparison","volume":"112","author":"De Ornelas","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.esmorw.2025.100680_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.phro.2022.07.006","article-title":"Lymphocyte-sparing pelvic radiotherapy for prostate cancer: an in-silico study","volume":"23","author":"Bar\u00e9","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100680_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00048.1","article-title":"IMPT versus VMAT for pelvic nodal irradiation in prostate cancer: a dosimetric comparison","volume":"5","author":"Whitaker","year":"2019","journal-title":"Int J Part Ther"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100680_bib53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2008.05.065","article-title":"Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation","volume":"72","author":"Widesott","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.esmorw.2025.100680_bib54","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac0681","article-title":"Spatial descriptions of radiotherapy dose: normal tissue complication models and statistical associations","volume":"66","author":"Ebert","year":"2021","journal-title":"Phys Med Biol"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820125005697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820125005697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:53:58Z","timestamp":1788670438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949820125005697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"alternative-id":["S2949820125005697"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100680","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100680"}}